A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis
EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment
30
Participants
Timeline
Start Date
September 14, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
Conditions
Primary Biliary Cholangitis (PBC)
Interventions
DRUG
Fenofibrate
Fenofibrate 200mg/day
DRUG
UDCA (Ursodeoxycholic acid)
UDCA 13-15mg/kg/day
Trial Locations (1)
710032
Xijing hospital, Xi'an
All Listed Sponsors
lead
Han Ying
OTHER
NCT06591455 - A Pilot Study of Fenofibrate and Ursodeoxycholic Acid in the Treatment of Newly Diagnosed Primary Biliary Cholangitis | Biotech Hunter | Biotech Hunter